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Background: Cerebral palsy (CP) results from a static brain lesion during pregnancy or early life and remains the
most common cause of physical disability in children (1 in 500). While the brain lesion is static, the physical
manifestations and medical issues may progress resulting in altered motor patterns. To date, there are no
prospective longitudinal studies of CP that follow a birth cohort to track early gross and fine motor development
and use Magnetic Resonance Imaging (MRI) to determine the anatomical pattern and likely timing of the brain
lesion. Existing studies do not consider treatment costs and outcomes. This study aims to determine the pathway(s)
to motor outcome from diagnosis at 18 months corrected age (c.a.) to outcome at 5 years in relation to the nature
of the brain lesion (using structural MRI).
Methods: This prospective cohort study aims to recruit a total of 240 children diagnosed with CP born in Victoria
(birth years 2004 and 2005) and Queensland (birth years 2006–2009). Children can enter the study at any time
between 18 months to 5 years of age and will be assessed at 18, 24, 30, 36, 48 and 60 months c.a. Outcomes
include gross motor function (GMFM-66 & GMFM-88), Gross Motor Function Classification System (GMFCS);
musculoskeletal development (hip displacement, spasticity, muscle contracture), upper limb function (Manual Ability
Classification System), communication difficulties using Communication and Symbolic Behaviour Scales-
Developmental Profile (CSBS-DP), participation using the Paediatric Evaluation of Disability Inventory (PEDI), parent
reported quality of life and classification of medical and allied health resource use and determination of the
aetiology of CP using clinical evaluation combined with MRI. The relationship between the pathways to motor
outcome and the nature of the brain lesion will be analysed using multiple methods including non-linear
modelling, multilevel mixed-effects models and generalised estimating equations.
Discussion: This protocol describes a large population-based study of early motor development and brain structure
in a representative sample of preschool aged children with CP, using direct clinical assessment. The results of this
study will be published in peer reviewed journals and presented at relevant international conferences.
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Cerebral Palsy (CP) is a disorder of movement and pos-
ture secondary to an insult to the developing brain [1].
The insult is static and permanent and may be the con-
sequence of different factors, including both genetic and
environmental causes. Although the insult is static, the
consequent symptoms are variable and may change over
time [2]. Children may have a range of associated dis-
abilities, including intellectual disability, hearing and vis-
ual deficits, nutritional and feeding problems, respiratory
infections and epilepsy [3,4]. Secondary musculoskeletal
disorders involving muscle, tendons, bones and joints
are common as a result of spasticity, muscle weakness
and immobility. CP has substantial lifelong effects on
daily function, societal participation and quality of life
(QOL) for children and their families.
Cerebral Palsy registers have provided us with some
understanding of the aetiologies of CP and specific out-
come studies [3]. Few studies have documented broad
clinical outcomes for an entire cohort of children with
CP prospectively. In addition, none of the existing
cohort studies have utilised their large patient groups to
better understand the aetiologies of CP, the relationship
between abnormalities on brain MRI and outcomes such
as motor disability [5] musculoskeletal deformity and
related development (communication, oromotor, fine
motor skills). A better understanding of the aetiology of
CP, the timing of the insult during brain development
and the anatomical pattern of injury or malformation is
required in order separate CP into different prognostic
or treatment groups and to determine the pathway to
motor outcome.
Previous studies [5-8] have reported the relative propor-
tions of GMFCS levels (GMFCS I: 27.9-40.7%, GMFCS II:
12.2%-18.6%, GMFCS III: 13.8%-18.6%, GMFCS IV: 11.4%-
20.9%, GMFCS V: 15.6%-20.5%), motor types (spastic:
78.2-86.4%, dyskinetic: 1.5%-6.1%, mixed: 6.5%-9.1%,
ataxia: 2.5%-2.8%, hypotonia: 2.8%-4.1%), and motor top-
ography (hemiplegia: 15.3%-40.0%, diplegia: 28.0%-46.4%,
quadriplegia: 13.6%-50.8%) within various CP cohorts
[6,9,10]. A recent systematic review investigating the
rates of co-occurring impairments, diseases and func-
tional limitations in CP concluded that for children
diagnosed at 5 years of age: 3 in 4 were in pain; 1 in 2
had an intellectual disability; 1 in 3 could not walk; 1 in
3 had hip displacement; 1 in 4 could not talk; 1 in 4
had epilepsy; 1 in 4 had a behaviour disorder; 1 in 4had bladder control problems; 1 in 5 had a sleep dis-
order; 1 in 5 dribbled; 1 in 10 were blind; 1 in 15 were
tube fed; and 1 in 25 were deaf [4]. Launched in 2007,
the Australian Cerebral Palsy Register [3] combines
data from several notable state-wide registries (inclu-
ding Queensland, Victoria, Western Australia and New
South Wales), and is one of the largest CP registers in
the world with over 3,000 children registered in the
1993–2003 birth cohort.
Hip displacement is the second most common muscu-
loskeletal problem in children with CP [11-14]. In the
most severely impaired, non-ambulatory children, the
incidence may be as high as 80% [11,15]. While children
with CP are born with enlocated hips, progression to hip
displacement is demonstrated in some children with CP
from a very early age [13,14,16]. Hip surveillance pro-
grams and appropriately-timed interventions improve
outcomes at skeletal maturity [14,15]. Although the final
outcome of early intervention at skeletal maturity is not
clear [17,18], early risk assessment might enable earlier
referral for those children who may benefit from pre-
ventative intervention [19]. As clinical assessment of hip
range of motion is a poor predictor of risk, several radio-
logical and clinical measures are used to diagnose and
monitor hip subluxation [13,16,17,19]. While functional
disability, pain [20] and impaired ambulatory weight-
bearing [12,16,18,19] are associated with risk of hip dis-
placement and need for surgical intervention, the evidence
regarding radiological characteristics is less clear [21,22].
There is a need for early prospective evaluation of radio-
logical development in a population of very young chil-
dren with CP across the spectrum of function severity in
order to aid prediction of hip development.
There have been several large studies that have evalu-
ated prospective motor development in children with
CP. The Ontario Motor Study (OMGS) collated over
2,632 GMFM assessments on 657 children with an ave-
rage of four observations per child [9]. The principal
outcome of the study was the development of two inter-
nationally accepted valid and reliable tools for measuring
motor function (the Gross Motor Function Measure,
GMFM) [9,23] and for classifying functional status into
five groups (Gross Motor Function Classification Sys-
tem, GMFCS) [24,25]. From these data, Growth Motor
curves for children with CP were developed [9]. These
curves are valid and reliable for children aged two years
and over and allow for tracking and predicting motor
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Two potential limitations of the Ontario Motor Study
were that it included only minimal data on children less
than 3 years of age and it was a not an entire population
based sample [9].
In the European Cerebral Palsy study [6], with a repre-
sentative cohort of children with CP from eight European
countries, children are classified according to brain injury
diagnosed using MRI. This group used a classification
system based on the presumed timing and nature of the
insult that resulted in CP and included both genetic and
non-genetic aetiologies such as genetic cortical malforma-
tions (e.g. lissencephaly) and hypoxic ischaemic injury
[6,10]. Again this cohort is representative rather than
entire population based and these investigators from Sur-
veillance of Cerebral Palsy in Europe (SCPE) have guided
our classifications of motor type and of the brain injury on
MRI [26-28].
Pathogenic events impacting on the brain cause diffe-
rent patterns of structural abnormality in CP [29]. These
pathogenic events may be environmental or genetic.
Their consequences will depend not only on the nature
of the event, but also the timing of the event during the
different stages of brain development (Figure 1). The 1st
and 2nd trimesters are the most critical times for cor-
tical development and are characterized by the sequen-
tial yet overlapping steps of proliferation, migration and
organization of neuronal cells and their connections.
Brain pathology secondary to events during these stages
of brain development is usually characterised by signifi-
cant malformations. During the 3rd trimester, growth
and differentiation events are predominant and persist
into postnatal life. Disturbances of brain development
during this period cause lesions, often of a different
pattern to those resulting from earlier insults orFigure 1 Major events in human brain development. Pathogenic event
malformations or lesions, the patterns of which will depend on the stage odevelopmental disorders. During the early 3rd trimester,
the periventricular white matter is especially affected;
whereas towards the end of the 3rd trimester grey mat-
ter, either cortical or deep grey matter, appears to be
more vulnerable. Understanding the aetiologies of CP in
the living patient has advanced significantly since the in-
creased use of MRI in the evaluation of children with
congenital or early-onset neurological deficits. Using
MRI, a number of studies have shown that the most
common causes of CP are structural brain lesions
[27,30-33], especially prematurity-related injuries, and
malformations of brain development [34-36]. Guidelines
by the American Academy of Neurology strongly recom-
mend that all children with a suspected diagnosis of CP
undergo neuroimaging, with MRI preferable to CT [37].
Determination of brain structural abnormality will pro-
vide a final diagnosis that is more than a label of ‘cere-
bral palsy’[38].
It is necessary to attempt to determine the underlying
aetiology/pathogenesis to confirm the suspicion of a
static lesion, exclude a treatable disorder and diagnose a
malformation, which may have significant genetic coun-
selling implications for the family. In addition, these pat-
terns of brain maldevelopments or lesions offer excellent
models to study the normal mechanisms of organisation
and reorganisation in the developing brain [30,31,39].
Despite these advances, limited studies exist correlating
the specific MR imaging appearance and outcome mea-
sures such as motor function [27]. Such data may prove
invaluable in providing accurate prognostic counselling
at the time of diagnosis, as well as potentially guiding
the most appropriate treatments tailored to each indivi-
dual’s pattern of CP and type of lesion on imaging.
A recent systematic review investigated the relation-
ship between brain structure on MRI and motors (both genetic and non-genetic) affect the developing brain to cause
f brain development during which the event occurs.
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comprising over 2300 subjects met inclusion criteria,
and these studies were analysed in terms of population
characteristics, MRI data, motor outcome data, and
where possible, the relationship between MRI data and
motor outcomes. The importance of MRI lesion descrip-
tion has been previously outlined, due to the presumed
relationships between lesion topography and motor type,
and between lesion extent and functional severity [27].
Indeed, Yokochi et al. [29] and Holmstrom et al. [41]
reported that in subjects with motor subtypes of athe-
tosis or hemiplegia respectively, motor disabilities were
more severe when lesions involved both grey and white
matter on MRI as opposed to grey or white matter in-
volvement alone. Similarly, Holmefur et al. [42] reported
that in subjects with spastic hemiplegia, those with more
severe white matter reduction on MRI had a significantly
lower development in hand function. A focus of current
research is the prevention of CP, which requires clinical
outcomes to be correlated with the presumed timing
and aetiology of lesions in the developing brain [43].
Pathological insults during brain development cause ab-
normalities or lesions which may be detected by brain
MRI, and the observable patterns of these lesions
depend on the stage of brain development [39]. Using
this principle, a qualitative classification system has
emerged whereby lesions can be identified as brain
maldevelopments, periventricular white matter lesions,
grey matter lesions, other miscellaneous lesions, or
normal MRI [27]. All studies included in the review
reported enough MRI data for subjects to be classified
into these broad lesion groups, and differences in motor
subtypes and functional disabilities were identified be-
tween groups [40]. Despite this, it was found that many
studies did not utilise valid and reliable classifications
and measures of motor abilities (e.g. GMFCS, GMFM,
and MACS), and heterogeneous measures were
employed which generally precluded pooled analysis. All
included studies also used a qualitative system of lesion
description or classification [27], and as such the specific
anatomical location and severity of brain pathology was
often overlooked. Ultimately, the authors concluded that
the relationship between MRI findings and motor out-
comes needs to be further investigated in a cohort of
children with CP using a valid, quantitative measure of
MRI classification which includes detailed information
about the location and extent of brain lesions, as well as
valid and reliable motor measures [40,44].
The limitation of many cohort studies of children with
CP in Canada [9], the USA, and across Europe [10] is
the difficulty obtaining a representative sample and an
entire cohort. The opportunity for undertaking entire
prospective cohort based studies is possible in Australia.
There is limited data on motor trajectories of an entirecohort of children with CP from diagnosis at 18 months
to 36 months of age and these motor trajectories have
not been correlated with MRI brain injury classification.
For the present study the age of 18–24 months for entry
has been chosen as diagnosis is usually confirmed by this
time. Children will be followed up till 5 years of age at
school entry when motor outcome has been well
classified [3]. The preferred age for structural MR im-
aging is from 24 months because by this age myelin-
ation of the brain should be complete, thus allowing
optimum differentiation between grey and white mat-
ter on MR imaging, important for the detection and
correct classification of brain injuries and malfor-
mations (Figure 2).
In the Australian CP child study (NHMRC 465128)
entire birth years of Victorian and Queensland born
children with CP are prospectively entered and will be
followed intensively to determine the relationship bet-
ween the rate and limit of motor development (gross
and fine motor function) as related to the nature of the
brain lesion. Secondarily the influence of musculoskel-
etal deformity (hip displacement, spasticity and muscle
contracture) and location and extent of brain injury will
be related to the rate and pattern of motor disability.
The parent report of their child’s ability to participate in
society and perceived quality of life will be compared
across motor severity. Finally the level of motor func-
tioning will be correlated with direct medical and allied
health costs and outcomes including school readiness
(see study flow chart, Figure 3). School readiness is a
framework for assessing profiles of strengths and vulner-
abilities of the preschool aged child [45]. It considers a
child’s readiness to learn within five major skill areas:
health and physical development, emotional well-being
and social competence, approaches to learning, commu-
nication skills, and cognitive skills and general know-
ledge [45].
Aims and hypotheses
This study aims to determine the pathway(s) to
motor outcome (gross and fine motor) from diagno-
sis at 18 months to outcome at 5 years in relation
to the nature of the brain lesion (using structural
MRI). These aims will be explored through the fol-
lowing hypotheses:
1 The rate of motor development (gross motor
function) from 18 months will be related to the
limit of attainment at 5 years (Gross Motor
Function Classification, GMFCS level).
2a The pattern of motor disability (motor type
and distribution) will correlate with the
location, presumed timing and nature of the
brain lesion(s).
Legend: MRI = Magnetic Resonance Imaging; MP = Migration Percentage; AI = Acetabular 
Index; GMFM = Gross Motor Function Measure; GMFCS = Gross Motor Function 
Classification system; MACs = Manual Assessment Classification system; PEDI = Pediatric 
Evaluation of disability Inventory.  CPQOL = Condition specific QOL measure 
(NHMRC 284514); Gait Pattern Classification.
Eligible subjects: All children diagnosed with CP 
born between 1st January 2004 to 31st December 
2005 in Victoria, and 1st January 2006 to 31st 
December 2009 in Queensland
Referred n= ?
Consent to participate n=240
Excluded
Children with a progressive or 
neurodegenerative lesion
Children born outside of Victoria or 
Queensland in the relevant birth 
years
Baseline 18 MONTHS 
CORRECTED AGE (n= 240)
Neuroimaging:  
Advanced Brain Imaging 
Impairment: Hip status 
at 8-10 years.
Activity:  GMFM, 
GMFCS level at 8-10 
Impairment: Range of motion 
Spasticity; Hip displacement (MP, AI).
Activity: GMFM, GMFCS level
Gait pattern; MACS, 
Participation: PEDI, CP- QOL
Medical Resource Use
FUTURE 
MRI @ 24 MONTHS for 
classification of brain Injury
36- 60 MONTH F/U
(annual) 2 visits
Impairment: Range of motion; 
Spasticity, Hip displacement 
(MP,AI).




Medical Assessment: including 
aetiology, perinatal, family history, 
presence of: epilepsy, respiratory health.
Communication (CBSB-DP).
Impairment: Range of motion;
Spasticity; hip displacement (MP, AI).
Activity: GMFM, GMFCS level
Gait Pattern; MACS, 
Participation: PEDI
Medical Resource Use
18 – 36 MONTH F/U 
Figure 3 Consort flowchart of study program.
Figure 2 Examples of different types of structural brain abnormalities in cerebral palsy All images are axial T2-weighted MRI scans.
Each image is subtitled by its presumed aetiology and timing during gestation. a is a child with lissencephaly showing cortical thickening and
agyria. b is a child with congenital cytomegalovirus infection showing an overfolded cortex (polymicrogyria), thin white matter and dilated lateral
ventricles. c is an ex premature child showing cystic white matter injury (arrows) consistent with periventricular leukomalacia. d is a child who
suffered a haemorrhagic stroke in the newborn period. There is cortical and white matter loss in the right frontal and parietal lobes (arrowheads)
consistent with previous ischaemia.
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or signs) will correlate with the location, extent and
nature of the brain lesion (on structural MRI).
3 The rate and limit of motor development will be
influenced by the severity of musculoskeletal
deformity (i.e. slower motor development will
correlate with marked hip displacement, increased
spasticity and reduced range of motion in the
lower limb).
4 Children with lower levels of function will have
higher direct medical and allied health costs.
Study significance
This unique project will
1. Allow clinicians to better predict the functional
outcomes of children with CP from an earlier age
based on their rate and limit of gross motor abilities
and nature and severity of their brain lesion.
2. Determine the nature and timing of physical
deformities including hip displacement to guide the
timing and intensity of interventions.
3. Provide comprehensive data on the relationship
between the nature of the brain lesion, rate of
musculoskeletal deformity and impact on the child’s
ability to participate in the community.
4. Information on resource use for future planning of
medical and therapy services.
Methods
All children diagnosed with CP, born in the years 1st
January, 2004 to 31st December, 2005 in Victoria,
Australia and 1st January 2006 till 31st December, 2009
born in Queensland, Australia will be entered (n = 240).
We define Cerebral Palsy as a permanent (but not un-
changing) disorder of movement and posture that results
from an insult to the developing central nervous system.
The characteristic signs are spasticity, movement disor-
ders, muscle weakness, ataxia and rigidity [43].
Exclusion criteria
1. Children with a progressive or neurodegenerative
lesion.
2. Children born outside of Victoria or Queensland in
the relevant birth years.
Ethics approvals
Ethics committee approvals have been gained through
The Royal Children’s Hospital Melbourne Ethics Com-
mittee, (HREC/25010 F), Southern Health Human
Research Ethics Committee C (05077C), University
of Queensland Medical Research Ethics Committee
(2007001784), the Children’s Health Services DistrictEthics Committee (HREC/07/QRCH/107), the Mater
Health Services Human Research Ethics Committee
(1186C), the Queensland Cerebral Palsy Register at the
Cerebral Palsy League of Queensland (CPLQ 2008/ 09–
1010), Gold Coast Health Service District Human Re-
search Ethics Committee (HREC/08/QGC/45), Central
Queensland Health Services District Human Research
Ethics Committee (HREC/08/QCQ/19), Cairns and
Hinterland Health Service District Human research Ethics
Committee (HREC/08/QCHHS/521) and the Townsville
Health Service District Human Research Ethics Commit-
tee (HREC/08/QTHS/33). There are no known health or
safety risks associated with participation in any aspect of
the described study. All families will give written informed
consent to participate, and they are able to withdraw their
child from the study at any time without explanation,
without any penalty from staff at the Royal Children’s
Hospital or University of Queensland, or any effect on
their child’s care. Data collected in this study will be stored
in a coded re-identifiable form (by ID number). Each child
has multiple assessment appointments across the duration
of the study, which necessitates data to be re-identifiable.
Ascertainment of the cohort
Prospective entry of birth years born in Victoria (born in
2004 and 2005) and Queensland (born in 2006, 2007,
2008, 2009) entered at 18 months will be followed until
school age (5 years) (n = 240-360). Study recruitment
commenced in July 2005 (at 18 months c.a.) for children
born in January 2004 and continues in Queensland
according the above birth years.
State wide recruitment has been established in collab-
oration with the relevant Cerebral Palsy Registers with
data collection at tertiary referral hospitals. Community
awareness has been generated through campaigns aimed
at paediatricians (Division of Paediatrics & Child
Health), general practitioners, allied health professionals,
maternal and child health nurses, and neonatal follow-
up clinics. These groups have been encouraged to refer
children with motor delay (not sitting at 10 months, not
standing at 12 months not walking at 24 months) for
confirmation of a diagnosis of cerebral palsy. Families of
children identified through the relevant CP Register have
been approached after permission to contact the family
has been given by their treating clinician or direct refer-
ral to the study by families whom have provided consent
to be entered onto the Queensland CP Register (QCPR).
Specialist clinics have been established at the tertiary
referral centres where suitability for the study can be
confirmed. In cases where the diagnosis of CP is unclear,
or where there is a suggestion of a progressive or degen-
erative course, further investigations (such as metabolic
screening) will be requested before a diagnosis of CP is
confirmed. Parents have then been invited to participate
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ment is expected for children with moderate to marked
motor delay (GMFCS III to IV) and this has been the
case for children born preterm and children referred to
surveillance clinics at tertiary referral centres. Children
born at term with mild motor delay (GMFCS level I, II)
and predominant lower limb involvement (diplegia) are
typically identified through the CP orthopaedic services
and spasticity management clinics. Children with hemi-
plegia (GMFCS level I and II) are detected early through
the surveillance clinics and occupational therapy ser-
vices. Children who are detected after 18 months of age
will be entered into the study at the time of diagnosis,
will be offered brain MRI at entry and be followed up
with serial motor assessments and other outcomes until
outcome at 5 years.
Measurements and procedures
Following confirmation of a diagnosis of CP, eligible chil-
dren are entered from 18 months corrected age. They will
be assessed for diagnostic criteria, co-morbidities and for
differential diagnosis by neurological assessment (by a
Paediatrician, Child Neurologist or Paediatric Rehabilita-
tion Specialist). Experienced Physiotherapy researchers
will perform all GMFM assessments adjacent to either
clinic visit and perform collection of range of motion, clin-
ical measures of spasticity, then rate GMFCS, gait pattern,
MACs and measures of pelvic radiographs according to
standardized protocols.
Primary measures
The aim of the present study is to gather information
regarding the longitudinal measurement of Gross Motor
Function (GMFM-66) from 18 months to 5 years [46]
and determine the aetiology of CP using clinical evalu-
ation combined with MRI (location, nature and structure
of the brain lesion) [27]. The lesion will be classified by
3 main criteria:
A. the anatomical features of the lesion:
i. localisation by tissue (e.g. cortical, white matter,
deep grey matter etc.)
ii. localisation by region (e.g. lobes involved,
laterality etc.)
iii. extent of lesion (e.g. generalised, hemispheric,
lobar etc.)
B. the presumed aetiology of the lesion: (i) genetic; (ii)
ischemic; (iii) infective and (iv) other.
C. the presumed timing of the insult that caused the
lesion:
i. Prenatal by trimester or by stage of brain
development;
ii. Perinatal;
iii. Postnatal.All MRIs will be classified by a neurologist together
with a neuroradiologist using a standardised method of
image evaluation and classification. Following these eval-
uations, consensus will be reached regarding the above
three criteria. We estimate that 70–80 percent of chil-
dren currently receiving a diagnosis of CP will have had
brain MRI as part of their clinical work-up. The American
Academy of Neurology has concluded that a brain MRI
should be part of the diagnosis of CP in a previous
practice parameter [37]. For Victorian patients, the
majority will have had their imaging performed and
reported through the Royal Children’s Hospital, Melbourne
or Monash Children’s Hospital Medical Imaging Depart-
ment on a GE Signa Echo Speed 1.5T MR scanner. For
Queensland patients, the majority will have had their im-
aging performed and reported through the Royal Chil-
dren’s Hospital, Brisbane Medical Imaging department on
a GE Signa Echo Speed 1.5T MR scanner. The current
minimum imaging protocol for patients with suspected
CP consists of axial fast spin echo and coronal fast spin
echo sequences and 3D inversion prepared fast spoiled
GRASS sequence. 3D acquisitions are reformatted in axial,
coronal and sagittal planes, with additional oblique and
curved reformatting. Age specific protocols are used to
maximize the ability to detect cortical and white matter
abnormalities at different stages of myelination. All
existing neuroimaging will be re-reviewed by a neurologist
familiar with the features of lesions that result in CP, most
commonly either white matter injury or congenital
malformations. A protocol will be used to describe the
features of each patient’s abnormality. The patient’s im-
aging will then be classified using a system, which takes
into account anatomical features, aetiology and presumed
timing of the “insult” causing the abnormalities. If no MR
imaging has been performed, or if previous imaging was
only CT scans or poor quality MRI scans, then an attempt
will be made to perform high quality MR imaging. Such
imaging will usually be necessary for clinical reasons to be
able to make an accurate diagnosis and exclude causes of
CP that may have genetic implications for other family
members. This approach is consistent with recent guide-
lines suggesting that all patients with the label of CP have
high quality MR imaging on at least one occasion [37].
For children scanned prospectively, this will be performed
at the either Paediatric Magnetic Resonance Imaging
Centres. All MRI scans will be performed clinically
under anaesthesia after informed consent.
Brain lesion severity will be assessed using a structured
scoring proforma [44] based on the CH2 template [47],
a highly detailed single-subject T1 template in MNI space,
which is the international standard for brain mapping
(International Consortium of Brain Mapping - ICBM).
Lesions will be transcribed onto the proforma and the
following measures obtained: number of (i) anatomical
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were affected and (iii) size and distribution of the lesion
measured by a global lesion score and lesion subscores.
The number of lobes and slices affected will be the ave-
rage of summed right and left hemispheres. To calculate
total lesion score, each frontal, parietal, temporal and oc-
cipital lobe will be first considered in three sections: peri-
ventricular, middle and subcortical matter. Each section
will be scored as 0.5 if less than 50% of area was involved;
or 1, for greater than 50% involvement, with a maximum
lobar score of 3. Lobar scores for each hemisphere will be
summed, with a maximum hemispherical score of 12 pos-
sible. The total lesion score will be the sum of right and
left hemispherical scores (maximum score 24). A 1-point
score (involved/not involved) will also be attributed to 16
anatomical structures including the corpus callosum, the
cerebellum and the main subcortical structures. The final
maximum score of the scale will therefore be 40 (24 + 16).
Gross motor function
At each assessment gross motor function is evaluated
using the GMFM-66 & GMFM-88 [46]. The GMFM-88
assesses childrens’ motor abilities in lying to rolling, sit-
ting, crawling to kneeling, standing, walking, running
and jumping. The GMFM-66 is comprised of a subset of
the 88 items identified (through Rasch analysis) as con-
tributing to the measure of gross motor function in chil-
dren with cerebral palsy. The GMFM-66 will be used to
provide an overall measure of gross motor function and
the GMFM-88 domain scores to explore specific motor
skills [46]. Measures of GMFM will be rated by experi-
enced research physiotherapists.
Secondary measures
Gross motor function classification system (GMFCS)
The Gross Motor Function Classification System (GMFCS)
is a five level classification system of children’s functional
gross motor severity. It is based on self-initiated move-
ments, anti-gravity postures and motor skills expected in a
typical five year old [25,26]. Children who are indepen-
dently ambulant are classified as GMFCS I or II, those
requiring an assistive mobility device to walk classified as
GMFCS III and those in wheeled mobility as GMFCS IV
and V. Two physiotherapists, trained in the use of the
GMFCS, independently observe and classify children in
one of five functional categories [25]. The GMFCS has
internationally established validity, reliability and stability
for the classification and prediction of motor function of
children with CP aged 2–12 years [24,25]. It has a high
inter-rater reliability (generalisability coefficient = 0.93)
[25]. Classifications of gross motor abilities change with
age, therefore separate descriptions are used for different
age bands. In the current study, the <2 years and 2–4 year
descriptions are used. Lower inter-rater reliability isdocumented for the <2 years age band (κ = 0.55), as youn-
ger children’s gross motor abilities are more variable, and
less developmental information is available on which to
base the classification [48]. The intra-rater (test retest) reli-
ability from <2-12 years appeared to be acceptable (gene-
ralisability coefficient = 0.68). The GMFCS has been
correlated with a number of motor scales, as well as CP
distribution and type of motor impairment [49].Motor type & distribution
Motor type of CP will be classified as spastic, dystonic,
ataxic, hypotonic, choreoathetosis, mixed CP or unclassifi-
able according to SCPE guidelines [28,50]. Distribution
will classified by number of limbs impaired (hemiplegia,
diplegia, triplegia, quadriplegia) by at least two independ-
ent raters [51].Motor performance
Functional performance will be scored on the Functional
Mobility Scale (FMS). This is a valid and reliable mea-
sure of a child’s usual walking ability at three distances
(5 m, 50 m and 500 m), representing their home, school
and wider community [52].Gait pattern classification
Gait patterns will be classified according to the Rodda
& Graham’s Classification for spastic diplegia [53,54],
which has demonstrated validity and reliability [53].
From least to most severe these were: (i) True Equinus,
(ii) Jump Knee, (iii) Apparent Equinus and (iv) Crouch
Gait. For children with unilateral CP, gait patterns will
be classified according to Winters & Gage [55]. This
classification considers the sagittal plane joint move-
ments. Group I: foot drop during swing phase (Apparent
Equinus). Group II: persistent ankle dorsiflexion (True
Equinus). Group III: maintained plantar flexion through
gait cycle plus limited knee flexion-extension. Group IV:
similar to III, plus reduced hip flexion-extension [53,56].
Winter’s classification [55] has good inter-rater reliability
using written reports (weighted kappa, wκ = 0.76) and
videos (wκ = 0.63) [57,58].Upper limb function
Upper limb function is classified using the Manual Ability
Classification system (MACs) [59]. The MACs is an inter-
national system to classify hand function based on the
child’s typical performance when handling objects in daily
activities. This classification system was developed for
children aged from 4–18 years, but has been shown to
have good reliability for use in children as young as two
years [59].
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Hip surveillance, including anterior-posterior (AP) pelvis
x-ray, is recommended for all Australian children with
CP to facilitate early detection and treatment of severe
or progressive hip displacement [14,60,61]. The migra-
tion percentage (MP) is widely accepted as the gold
standard measure in hip surveillance [12,62], measuring
femoral head subluxation. Other measures include the
acetabular index (AI), assessing acetabular dysplasia [63],
and the femoral neck-shaft angle (NSA) [64,65]. As the
pelvis and its radiographic appearance changes between
birth and skeletal maturity [66], early surveillance may
be impacted by bony growth and ossification, particu-
larly if measurements are based on landmarks that are
difficult to identify or absent in the immature skeleton.
The reliability of migration percentage has been inves-
tigated in relatively small studies to date [67,68], and
reliability data in very young children is infrequent.
Hilgenreiner’s Epiphyseal Angle (HEA) [69] is a ra-
diographic measure describing the proximal femoral
epiphysis and has been previously applied to assessment
of coxa valga [70,71], but may offer prognostic informa-
tion for hips at risk in cerebral palsy. It is the acute angle
between a line drawn parallel to and through the pro-
ximal femoral epiphysis and Hilgenreiner’s line [69].
Musculoskeletal development
A comprehensive musculoskeletal examination will be
performed by paediatric physiotherapists recording data
relating to joint range of movement, muscle length, leg
length difference, bony anomalies, motor type and
muscle contracture.
Clinical history and examination
At study entry including a comprehensive clinical his-
tory and examination at study entry is performed by a
paediatrician, child neurologist or rehabilitation phys-
ician. The following information is collected:
a. Presence or absence of vision impairment, hearing
difficulties; epilepsy;
b. Feeding issues including presence or absence of
gastrostomy tube and failure to thrive;
c. Respiratory difficulties including episodes of
pneumonia and aspiration;
d. Speech and language development.
Participation
Children’s participation will be assessed (i) via parent-
report on the domains of self-care, mobility and social
functioning using the scaled scores of the Paediatric
Evaluation of Disability Inventory (PEDI) which has
good validity and reliability [72-74] and (ii) parent per-
ception of health related quality of life using a conditionspecific tool the CPQOL-child by parent report [75,76]
at 5 years.
Medical and allied health resource use
In order to determine the relationship between motor
prognosis and medical and allied health resource use,
the direct costs of treatment will be monitored and com-
pared to outcomes with adjustment for confounders
such as disease severity.
Communication
Communication difficulties will be examined by parent
self-report on the Communication and Symbolic Beha-
viour Scales–Developmental Profile (CSBS-DP) Infant-
Toddler Checklist [77,78] (24 parent rated items) and
the Communication Function Classification System
(CFCS) [79]. The CSBS-DP screening tool is a parent
questionnaire comprised of three composite subtests:
social, speech and symbolic, and a total score. The social
composite, composed of 13 questions, investigates the
child’s ability to functionally communicate, use eye gaze
and gesture. The speech composite, comprising five
questions, examines the sounds and words the child uses
and their ability to combine words. The symbolic com-
posite, comprising of six questions, explores the child’s
understanding of language and their ability to appropri-
ately use objects such as a cup, spoon, toy telephone,
stacking blocks, and participation in pretend play. Raw
scores for each composite were converted into standar-
dized scores (SS) where the M = 10 (standard deviation,
SD ± 3). The total score for the CSBS-DP was calculated
by adding the raw composite scores, then converting to
SS with M =100 (SD ± 15) [77]. The CSBS-DP manual
recommends all children with SS ≤ six on composites,
or ≤ 81 on the total score, be referred for further speech
and language evaluation. The CSBS-DP Infant-Toddler
Checklist has been shown to have high test-retest relia-
bility (r range = 0.79 to 0.88) [77], a strong predictive
relationship with expressive and receptive language
(R = 0.55 and 0.71 respectively) and high sensitivity and
specificity (76% and 82% respectively) at two years of
age [77,78]. The Communication Function Classification
System (CFCS) will be used to classify everyday commu-
nication performance of individuals with cerebral palsy
into five classification levels [79]. All methods of com-
munication performance are used in assigning the level
of function, including both informal (gesture, behaviour),
and formal (speech and symbolic communication sys-
tems). The classification has good inter-rater reliability,
conducted on 69 children aged 2-18 years (0.66 overall,
and 0.77 for children older than 4 years), and excellent
test-retest reliability (0.82) [79].
Neurological Examination: Existing data regarding the
child’s neurological examination will be reviewed.
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examination by a rehabilitation specialist, developmental
paediatrician or paediatric neurologist. It will be under-
taken again if this has not been performed or docu-
mented comprehensively by such specialists within the
previous six months.
Epilepsy
Epilepsy is common in CP, occurring in around 50% of
children [80-82]. The presence of poorly controlled epi-
lepsy or excessive anticonvulsant medications may con-
found an accurate assessment of each child’s clinical
state. For this reason we will obtain data on each child’s
pattern of epilepsy including age of onset, seizure type,
frequency and medications.
Data analysis plan
A comprehensive database has been established for all
data collection, including clinical measures, MRI scoring
and questionnaires so that it is entered prospectively at
the time of each assessment. Summary reports are auto-
matically generated from the database to report back to
families and treating clinicians after each visit. Our
biostatistician will supervise the statistical methods pro-
posed in this study, including analysis of binary out-
comes in longitudinal studies using weighted estimating
equations (e.g. presence of co morbidities); multilevel
mixed-effects models of longitudinal binary outcomes
(e.g. GMFCS levels), and generalised estimating equations
for ordinal data.
For hypothesis I: Raw GMFM total score will be
converted to GMFM-66, Rasch analysed scores. The
GMFM-66 data will then be plotted by age in months
for the entire cohort then according to GMFCS group.
Parameters of a non-linear model of motor development
will be estimated using non-linear fixed effects mode-
lling for children according to their GMFCS level. The
model uses two parameters, the estimated rate and limit
of motor development. Other complex, longitudinal ana-
lysis methods such as multilevel mixed-effects models
and generalised estimating equations [83] will also be
employed to look at the temporal relationships between
motor trajectories and classifications of brain structure
on MRI (Hypothesis 1, 2), and musculoskeletal deform-
ities (Hypothesis 3). For Hypothesis 4 groups of children
(by GMFCS level) will be compared economically by
incremental cost effectiveness and cost utility ratios.
Sample size calculations
For Hypothesis 1 six measurements are planned for each
participant between 18 months and 5 years of age. A
sample size of 40–50 per group (GMFCS I-V will give a
total of 240 patients) for a two-group comparison of
slopes in a linear model of motor development will have80% power [9] of detecting if there is a difference be-
tween the GMFM curves based on initial GMFCS
groups. This range allows for a range of possible effect
sizes (based on results of Rosenbaum et al. [9]), and a
range of between- and within-person variability in
GMFM measurements over time (allowing for a linear
pattern of motor development based on data from our
own study of 90 children over 3 years (NHMRC
980753). The initial GMFCS classification is the primary
predictor variable and GMFM-66 score at five subse-
quent time points will measure the pathway to motor
outcomes. In the event that children are diagnosed after
18 months corrected age they will be entered at the
age of diagnosis and will drop in to the study at entry.
Previous ascertainment rates suggest that children will
be identified by 2–3 years which would allow a mini-
mum of 3–5 data points for analysis, appropriate for
linear modelling.
For Hypothesis 2 for comparisons among MRI classifi-
cation levels (anticipating 43% PVL brain loss, 16% BG
damage, 16% cortical/subcortical, 12% malformation/
miscellaneous, and 10% normal from [5], or comparisons
among GMFCS levels (anticipating 36% level I, 16% II,
14% III, 16% IV, 18% V: [6]) we need a total cohort of
approximately 250 children. For the non-linear model of
motor development, sample size calculation is complex
however 80 subjects per group with 4 GMFM measure-
ments was sufficient to estimate the asymptotic limit
parameter with precision ± 3 GMFM-points (width of
95% confidence interval) in a similar population [9]. A
study of approximately 40 per group with 6 measure-
ments will have slightly lower precision for this param-
eter but should be sufficient for identifying differences
between GMFCS groups as the differences are large
(>10 GMFM-points) [9].
Discussion
This study protocol describes the rationale, aims, hypoth-
eses and methods for a large prospective longitudinal
population-based study of early motor development and
brain structure in a representative sample of preschool
aged children with Cerebral Palsy, using direct clinical as-
sessment. The results of this study will be published in
peer reviewed journals and presented at relevant inter-
national conferences.
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